Genomic amplification was reported as one cause of SNHG17 overexpression in non-small-cell lung cancer (NSCLC), and knockdown of SNHG17 inhibited the proliferation and migration and promoted the apoptosis of NSCLC cells with unknown mechanisms [35]. This evidence concerns the gene SNHG17 and non-small cell lung carcinoma.